Even though anti-tumorigenic functions [57] and a favorable clinical outcome have been linked to PGI2 in several cancers, increased intra-tumoral PTGIS expression derived from stroma cells is associated with poor clinical outcome in HGSC (Figure 2A) suggesting an entity-specific role for PTGIS and its product PGI2. Here, PTGIS is linked to cancer.